Recent Quotes (30 days)

You have no recent quotes
chg | %

IMRIS Inc  

(Public, TSE:IM)   Watch this stock  
Find more results for IM
0.600
-0.020 (-3.23%)
Oct 24 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.60 - 0.63
52 week 0.50 - 3.20
Open 0.62
Vol / Avg. 67,100.00/13,605.00
Mkt cap 31.20M
P/E     -
Div/yield     -
EPS -0.87
Shares 52.03M
Beta 1.14
Inst. own 11%
Oct 28, 2014
Q3 2014 IMRIS Inc Earnings Release Add to calendar
Sep 18, 2014
IMRIS Inc at Craig-Hallum Alpha Select Conference
Aug 14, 2014
IMRIS Inc at Canaccord Genuity Growth Conference
Aug 7, 2014
Q2 2014 IMRIS Inc Earnings Call
Aug 7, 2014
Q2 2014 IMRIS Inc Earnings Release
Aug 6, 2014
IMRIS Inc at CFA Society of Minnesota's InvestMNt Conference
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -165.03% -91.22%
Operating margin -159.28% -85.37%
EBITD margin - -66.55%
Return on average assets -37.92% -50.14%
Return on average equity -114.85% -98.12%
Employees 137 -
CDP Score - -

Address

100, 1370 Sony Place
WINNIPEG, MB R3T 1N5
Canada
+1-204-4807090 (Phone)
+1-204-4807071 (Fax)

Website links

Description

IMRIS Inc. (IMRIS) designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians. Designed to enable hospital´┐Żs clinical application needs, the VISIUS Surgical Theatre can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality. IMRIS sells the VISIUS Surgical Theatres globally to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets. The VISIUS Surgical Theatre incorporates magnetic resonance imaging, CT and fluoroscopy into multi-purpose surgical suites to provide truly intra-operative imaging for specific medical applications.

Officers and directors

H. David Graves Chairman of the Board
Jay D. Miller President, Chief Executive Officer, Chief Operating Officer
Age: 52
Mark Reade Executive Vice President - Global Sales
Amy Boyle Executive Vice President - Marketing
Denis A. Sutton Executive Vice President - Human Resources
Meir Dahan Executive Vice President - Research and Development
R. Stephen Armstrong Director
Age: 63
James B. Hickey Jr. Director
Age: 57
Carey Joseph Diamond Independent Director
William C. Fraser Independent Director